chr13-32443611-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000380121.7(N4BP2L2):n.897C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000316 in 1,612,090 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 3 hom. )
Consequence
N4BP2L2
ENST00000380121.7 non_coding_transcript_exon
ENST00000380121.7 non_coding_transcript_exon
Scores
17
Clinical Significance
Conservation
PhyloP100: -0.811
Genes affected
N4BP2L2 (HGNC:26916): (NEDD4 binding protein 2 like 2) Enables enzyme binding activity. Involved in negative regulation of hematopoietic stem cell differentiation and positive regulation of hematopoietic stem cell proliferation. Located in nucleus. Part of transcription repressor complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010247409).
BP6
Variant 13-32443611-G-A is Benign according to our data. Variant chr13-32443611-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2350074.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
N4BP2L2 | NM_001320836.3 | c.2213C>T | p.Thr738Ile | missense_variant | 7/10 | NP_001307765.1 | ||
N4BP2L2 | NM_001387001.1 | c.2213C>T | p.Thr738Ile | missense_variant | 7/10 | NP_001373930.1 | ||
N4BP2L2 | NM_001387002.1 | c.2213C>T | p.Thr738Ile | missense_variant | 7/10 | NP_001373931.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
N4BP2L2 | ENST00000380121.7 | n.897C>T | non_coding_transcript_exon_variant | 5/8 | 1 | |||||
N4BP2L2 | ENST00000674422.1 | c.2213C>T | p.Thr738Ile | missense_variant | 8/8 | ENSP00000501390 | ||||
N4BP2L2 | ENST00000399396.7 | c.926C>T | p.Thr309Ile | missense_variant | 7/10 | 5 | ENSP00000382328 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152174Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
52
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000413 AC: 102AN: 246754Hom.: 0 AF XY: 0.000411 AC XY: 55AN XY: 133830
GnomAD3 exomes
AF:
AC:
102
AN:
246754
Hom.:
AF XY:
AC XY:
55
AN XY:
133830
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000314 AC: 458AN: 1459798Hom.: 3 Cov.: 33 AF XY: 0.000342 AC XY: 248AN XY: 726024
GnomAD4 exome
AF:
AC:
458
AN:
1459798
Hom.:
Cov.:
33
AF XY:
AC XY:
248
AN XY:
726024
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000341 AC: 52AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74464
GnomAD4 genome
AF:
AC:
52
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
22
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
54
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MVP
MPC
0.037
ClinPred
T
GERP RS
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at